Intelligent Bio Solutions (INBS) Operating Margin (2019 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Operating Margin of 351.28% in Q1 2025, up 5.76% quarter-over-quarter from 372.76% in Q4 2024, and up 727.0% on a YoY basis from 42.48% in Q1 2024.
Intelligent Bio Solutions (INBS) Operating Margin (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' Operating Margin history runs 7 years deep, the most recent figure standing at 351.28% for Q1 2025.
- In Q1 2025, Operating Margin rose 727.0% year-over-year to 351.28%; the TTM figure through Mar 2025 stood at 341.7% (up 1818.0% YoY), while the FY2023 annual figure was 1002.11%, down 46914.0% from the prior year.
- Operating Margin was 351.28% for Q1 2025 at Intelligent Bio Solutions, up from 372.76% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 174.89% in Q2 2022 to a low of 9158.69% in Q1 2021.
- Historically, Operating Margin has averaged 1143.01% across 5 years, with a median of 358.55% in 2024.
- The sharpest annual moves came in 2021 and 2022: Operating Margin slumped 727846 bps in 2021, then surged 846112 bps in 2022.
- A 5-year view of Operating Margin shows it stood at 1949.84% in 2021, then surged by 69 bps to 597.45% in 2022, then jumped by 56 bps to 260.63% in 2023, then plunged by 43 bps to 372.76% in 2024, then grew by 6 bps to 351.28% in 2025.
- The last three Operating Margin figures came in at 351.28% (Q1 2025), 372.76% (Q4 2024), and 312.43% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -351.28% |
| Dec 31, 2024 | -372.76% |
| Sep 30, 2024 | -312.43% |
| Mar 31, 2024 | -358.55% |
| Dec 31, 2023 | -260.63% |
| Sep 30, 2023 | -317.35% |
| Jun 30, 2023 | -609.86% |
| Mar 31, 2023 | -1,431.63% |
| Dec 31, 2022 | -597.45% |
| Sep 30, 2022 | -350.62% |
| Jun 30, 2022 | -174.89% |
| Mar 31, 2022 | -697.57% |
| Dec 31, 2021 | -1,949.84% |
| Jun 30, 2021 | -201.67% |
| Mar 31, 2021 | -9,158.69% |
| Dec 31, 2020 | -324.10% |
| Sep 30, 2020 | -1,196.16% |
| Jun 30, 2020 | 4,405.44% |
| Mar 31, 2020 | -1,880.23% |
| Dec 31, 2019 | -213,523.18% |